MedPath

Lidocaine

Lidocaine 5% Ointment

Approved
Approval ID

f18be373-09d2-6fc3-e053-2a95a90a2a06

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 10, 2023

Manufacturers
FDA

Advanced Rx Pharmacy of Tennessee, LLC

DUNS: 117023142

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Lidocaine

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code80425-0249
Application NumberANDA205318
Product Classification
M
Marketing Category
C73584
G
Generic Name
Lidocaine
Product Specifications
Route of AdministrationTOPICAL
Effective DateJanuary 10, 2023
FDA Product Classification

INGREDIENTS (1)

LIDOCAINEActive
Quantity: 50 mg in 1 g
Code: 98PI200987
Classification: ACTIB

Drug Labeling Information

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

LOINC: 51945-4Updated: 1/10/2023

Principal Display Panel

label 1

SPL UNCLASSIFIED SECTION

LOINC: 42229-5Updated: 1/10/2023

SPL Unclassified Section

FOR TOPICAL USE ONLY
DO NOT USE IN THE EYES

Rx Only

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Lidocaine - FDA Drug Approval Details